Can varicella immunization change the course of herpes zoster while herpes zoster vaccine is underway?

References

• Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster. Recommendations of Advisory Committee on Immunization Practice (ACIP). Morb. Mortal. Wkly Rep.57(28), 1–30 (2008).
   PubMedGoogle Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med.58(1), 9–20 (1965).
   PubMedGoogle Scholar
• Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis.4(1), 26–33 (2004).
   PubMed Web of Science ®Google Scholar
• Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine20(19–20), 2500–2507 (2002).
   PubMed Web of Science ®Google Scholar
• Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics122(3), e744–e751 (2008).
   PubMed Web of Science ®Google Scholar
• Vazquez M, LaRussa PS, Gershon AA et al. Effectiveness over time of varicella vaccine. JAMA291(7), 851–855 (2004).
   PubMed Web of Science ®Google Scholar
• Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust. NZ J. Public Health29(6), 544–551 (2005).
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella vaccination-associated decreases in the incidence of varicella, 1992–2002. J. Infect. Dis.191(12), 2002–2007 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case–control study. Lancet360(9334), 678–682 (2002).
   PubMed Web of Science ®Google Scholar
• Vazquez M, La Russa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N. Engl. J. Med.344(13), 955–960 (2001).
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes zoster in older adults. Clin. Infect. Dis.32(10), 1481–1486 (2001).
   PubMed Web of Science ®Google Scholar
• Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J. Infect. Dis.197(Suppl. 2), S207–S215 (2008).
   PubMed Web of Science ®Google Scholar
• Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam. Pract.19(5), 471–475 (2002).
   PubMed Web of Science ®Google Scholar
• Arvin A. Aging, immunity, and the varicella-zoster virus. N. Engl. J. Med.352(22), 2266–2267 (2005).
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Starr SE, Connor K, Morton D. Zoster in normal children after varicella vaccine. J. Infect. Dis.159(5), 1000–1001 (1989).
   PubMedGoogle Scholar
• Law BJ, Chateau D, Walld R, Roos L. Temporal trends in the annual population-based incidence of herpes zoster by age and gender: Manitoba, 1979–1998. Can. J. Infect. Dis. Med. Microbiol.15(5), 357–358 (2004).
   Google Scholar
• Wagenpfeil S, Neiss A, Wutzler P. Effects of varicella vaccination on herpes zoster incidence. Clin. Microbiol. Infect.10(11), 954–960 (2004).
   PubMedGoogle Scholar
• Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, Tyring SK. Family history as a risk factor for herpes zoster: a case–control study. Arch. Dermatol.144(5), 603–608 (2008).
   PubMed Web of Science ®Google Scholar
• Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol. Infect.108(3), 513–528 (1992).
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier S, Wollan P, Sauver JS, Kurland M, Sy L. A population-based study of the incidence and complications of herpes zoster before zoster vaccine introduction. Mayo Clin. Proc.82(11), 1341–1349 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson RW, Wasner G, Saddier P, Baron R. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging25(12), 991–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost–effectiveness of vaccination in England and Wales. Vaccine19(23–24), 3076–3090 (2001).
   PubMed Web of Science ®Google Scholar
• Chidiac C, Bruxelle J, Daures JP et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin. Infect. Dis.33(1), 62–69 (2001).
   PubMed Web of Science ®Google Scholar
• Pérez-Farinós N, Ordobás M, García-Fernández C et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004. BMC Infect. Dis.7(1), 59–77 (2007).
   PubMedGoogle Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol. Infect.137(1), 38–47 (2009).
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B et al. Epidemiology of varicella-zoster virus in Canada and the United Kingdom. Epidemiol. Infect.127(2), 305–314 (2001).
   PubMed Web of Science ®Google Scholar
• Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine27(4), 520–529 (2009).
   PubMedGoogle Scholar
• Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore)61(5), 310–316 (1982).
   PubMed Web of Science ®Google Scholar
• Donahue JG, Choo PW, Manson J, Platt R. The incidence of herpes zoster. Arch. Intern. Med.155(15), 1605–1609 (1995).
   PubMed Web of Science ®Google Scholar
• Richards P. Shingles in one family practice. Arch. Fam. Med.5(1), 42–46 (1996).
   PubMedGoogle Scholar
• Araújo LQ, Macintyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes14(Suppl. 2), S40–S44 (2007).
   PubMedGoogle Scholar
• Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics114(3), 786–792 (2004).
   PubMedGoogle Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella and implementation of varicella vaccination in the United States. N. Engl. J. Med.352(5), 450–458 (2005).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention: Decline in annual incidence of varicella – selected states, 1990–2001. Morb. Mortal. Wkly Rep.52(37), 884–885 (2003).
   PubMedGoogle Scholar
• Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA294(7), 797–802 (2005).
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997–2002. Epidemiol. Infect.133(2), 245–253 (2005).
   PubMed Web of Science ®Google Scholar
• Yih WK, Brooks DR, Lett SM et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health5(1), 68 (2005).
   PubMed Web of Science ®Google Scholar
• Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect. Control Hosp. Epidemiol.29(12), 1157–1163 (2008).
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J. Infect. Dis.197(Suppl. 2), S224–S227 (2008).
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med.352(22), 2271–2284 (2005).
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Virapongse A, Smith KJ. Cost–effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin. Infect. Dis.44(10), 1280–1288 (2007).
   PubMed Web of Science ®Google Scholar
• Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N. Engl. J. Med.325(22), 1545–1550 (1991).
   PubMed Web of Science ®Google Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Prevention of Varicella. Recommendations of Advisory Committee on Immunization Practice (ACIP). Morb. Mortal. Wkly Rep.56(RR-4), 1–40 (2007).
   PubMedGoogle Scholar
• Ferguson NM, Anderson RM, Garnett GP. Mass vaccination to control chickenpox: the influence of zoster. Proc. Natl Acad. Sci. USA93(14), 7231–7235 (1996).
   PubMed Web of Science ®Google Scholar